Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 127.94M | $ 20.27M | $ 107.68M |
3/31/2025 | $ 143.21M | $ 18.95M | $ 124.26M |
12/31/2024 | $ 62.14M | $ 21.74M | $ 40.4M |
9/30/2024 | $ 79.82M | $ 20.96M | $ 58.87M |
6/30/2024 | $ 99.57M | $ 23.56M | $ 76.01M |
3/31/2024 | $ 118.06M | $ 18.88M | $ 99.18M |
12/31/2023 | $ 141.08M | $ 23.91M | $ 117.18M |
9/30/2023 | $ 74.64M | $ 22.47M | $ 52.17M |
6/30/2023 | $ 94.24M | $ 27.23M | $ 67.02M |
3/31/2023 | $ 109.43M | $ 28.08M | $ 81.35M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for ALIGOS THERAPEUTICS INC is calculated as follows: AssetsC [ $ 73.69M ] - LiabilitesC [ $ 19.98M ]
(=) Working Capital [ $ 53.71M ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.5M |
median | $ 32.21M |
std | $ 173.86M |